As mentioned in attached file
Awaiting price reaction for this filing.
Sellwin Traders' board, meeting on July 31, 2025, approved raising funds by issuing up to 4.75 crore convertible warrants at a minimum price of Rs. 8.40 per warrant (including premium). Each warrant can be converted into one equity share of Rs. 2 face value within 18 months, with 25% payable upfront and the rest on exercise. The warrants are being allotted to 103 identified allottees, mostly individuals, HUFs, and one company (Mideast Healthcare Pvt Ltd getting the largest 40 lakh warrants). The board also approved increasing authorized share capital from Rs. 50 crore to Rs. 58.40 crore to accommodate the issue. A postal ballot will be conducted for shareholder approval.
This is a significant equity dilution event — if all warrants are exercised, around 4.75 crore new shares will be issued, roughly a ~17% expansion of the share base. Existing shareholders will see their stake reduced accordingly. The pricing at Rs. 8.40 per share (minimum) and the wide spread of small allottees suggests a promoter/group fundraising rather than institutional capital raising, which existing shareholders should weigh carefully.